Cyclosporine, Modfied Capsule, Liquid Filled
Product Images NDC 60505-4631

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cyclosporine, Modfied (NDC 60505-4631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ctn100mg30s.jpg (Ctn100mg30s)

CycloSPORINE Capsules USP (MODIFIED) 100 mg soft gelatin capsules, packaging carton from Apotex Corp. The label states 30 soft gelatin capsules with the NDC 60505-4632-3. It includes a warning that these capsules are not bioequivalent to Sandimmune (cyclosporine capsules, USP nonmodified). Manufactured in Canada for Apotex Corp., Weston, FL 33326 USA.*

FDA Label Image

Ctn25mg30s.jpg (Ctn25mg30s)

Packaging label for CycloSPORINE Capsules USP (MODIFIED) by Apotex Corp., 25 mg strength, oral liquid filled soft gelatin capsules. The label indicates a package of 30 capsules with warning information stating these modified capsules are not bioequivalent to Sandimmune capsules and should not be interchanged without physician supervision. The label includes NDC 60505-4630-3 and manufacturing information for Apotex Corp., Weston, FL.*

FDA Label Image

Ctn50mg30s.jpg (Ctn50mg30s)

Packaging label for CycloSPORINE Capsules, USP (MODIFIED) 50 mg soft gelatin capsules by Apotex Corp. The label indicates 30 capsules per container with the NDC 60505-4631-3. The label includes a warning that these modified capsules are not bioequivalent to Sandimmune and should not be used interchangeably without a physician's supervision. Manufacturing information notes the product is made in Canada for Apotex Corp., Weston, FL.*

FDA Label Image

Cyclosporine-acrresponse.jpg (Cyclosporine Acrresponse)

Bar chart titled 'ACR Responders Randomized' displaying percentage response rates for various treatments including Cyclosporine (CsA), Methotrexate (Mtx), placebo (pla), and combinations thereof across multiple study groups (651, 652, 2008, 654, 302). P-values comparing CsA versus Mtx and CsA versus modified Cyclosporine capsules are noted above respective bars.*

FDA Label Image

Structure (Structure)

Chemical structure of Cyclosporine, the active ingredient in CycloSPORINE, Modified. The diagram shows the molecular formula C62H111N11O12 and its molecular weight of 1202.61 g/mol, illustrating the arrangement of atoms and bonds in the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.